FDA
staff flags concerns about Pfizer?s quit-smoking drug study
(Reuters) – U.S. Food and
drug Administration scientists have expressed
concerns about a post-marketing
study of Pfizer Inc’s
drug Chantix, which is aimed at helping *****rs quit, according to documents posted on the regulator’s website.
